• Протек
  • Протек 2
  • Протек 4

Protek held a conference for pharmaceutical manufacturers

On November 18, 2014 CV Protek held a conference for suppliers of medicines and parapharmaceutical products. The topics of the discussions included the current trends of the Russian pharmaceutical market, the principles of cooperation with distributors in the new economic environment and the future strategy of cooperation with suppliers. Particular emphasis was placed on the new approach of CV Protek to the product range management, as well as on the increase of profitability and on partnership projects.

Vadim Muzyaev, President of Protek, Dmitry Pogrebinsky, CEO of CV Protek, Boris Popov, Commercial director of CV Protek, presented their reports at the conference, and Nikolay Demidov, Director General of IMS Health Russia and CIS, made review of the market as an independent expert.

The event included a panel discussion of the following representatives of leading pharmaceutical manufacturers: Ivan Glushkov, Director of the External Relations Department (Stada CIS), Vladimir Boyko, Head of the Effective Sales Department (Bayer Consumer Health), Nikolai Soloviev, Head of Representative Office (Unipharm), Attila Varadi, Head of Representative Office (Gedeon Richter), Vitaly Smerdov, Director General (PharmFirm "Sotex"). The discussion was moderated by Nikolay Demidov. Participants shared their views on the development of the market situation in 2015 and the principles of cooperation with distributors.
Closing remarks were made by Vadim Yakunin, Chairman of the Board of Directors of Protek Group. He thanked all the suppliers for their long-term cooperation with Protek, mentioned that the company is steadily developing and expressed readiness to mutually beneficial cooperation in difficult economic conditions.

Summing up, Vadim Yakunin stressed the importance of distribution for the Russian pharmaceutical market and its role in the product supply chain between the manufacturer and the chemist’s shop.

Vadim Yakunin: “debt bubble” of pharmacies reached the critical volume of 1.7 billion dollars

Vadim Yakunin named problems which brought the Russian pharmaceutical market to the edge of global collapse: no... more...

CV PROTEK is atop the distributors rating in 2017

In 2017 the company accounted for 18.4% share of the direct sales market, with 7.1% increase of direct sales. ... more...

ProApteka and Rigla launched an electronic trading project

The project is being carried out at the Sberbank AST electronic platform (www.sb... more...